Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice.
Hu X, Manner K, DeJesus R, White K, Gattis C, Ngo P, Bandoro C, Tham E, Chu EY, Young C, Wells F, Basco R, Friera A, Kangeyan D, Beauchesne P, Dowdle WE, Deuse T, Fry TJ, Foster AE, Schrepfer S.
Hu X, et al. Among authors: deuse t.
Nat Commun. 2023 Apr 10;14(1):2020. doi: 10.1038/s41467-023-37785-2.
Nat Commun. 2023.
PMID: 37037829
Free PMC article.